Study Data from University Center of Health Sciences (CUCS) Provide New Insights into Biomarkers (P- 43 Pirfenidone Prevents Neoplastic Lesions Development By Oxidative, Fibrogenic, Antiproliferative And Epigenetic Mechanisms Regulation in A...).
In: Drug Week, 2023-04-14, S. 2785-2785
serialPeriodical
Zugriff:
Keywords: Antiinflammatory Agents; Biomarkers; Diagnostics and Screening; Drugs and Therapies; Genetics; Health and Medicine; Pharmaceuticals; Pirfenidone Therapy; Risk and Prevention EN Antiinflammatory Agents Biomarkers Diagnostics and Screening Drugs and Therapies Genetics Health and Medicine Pharmaceuticals Pirfenidone Therapy Risk and Prevention 2785 2785 1 04/10/23 20230414 NES 230414 2023 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New study results on biomarkers have been published. According to the news editors, the research concluded: "PFD prevents neoplastic lesions development by modulating antifibrogenic, antioxidant, and antiproliferative processes and modulating epigenetic marks to reverse global DNA hypomethylation.". [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Study Data from University Center of Health Sciences (CUCS) Provide New Insights into Biomarkers (P- 43 Pirfenidone Prevents Neoplastic Lesions Development By Oxidative, Fibrogenic, Antiproliferative And Epigenetic Mechanisms Regulation in A...).
|
---|---|
Zeitschrift: | Drug Week, 2023-04-14, S. 2785-2785 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|